Search on ZonMw
Search on the website
Filters
The results are updated as soon as you change a filter.
68
results found for 'Bacteria'.
Fifteen recently graduated scholars can do their research at foreign research institutes thanks to a Rubicon grant from NWO and ZonMw. For many researchers, experience abroad is an important step in their career. The Rubicon programme gives young, highly promising researchers the opportunity to gain international research experience.
This publication provides a recap of the online symposium ‘Microplastics and human health research in The Netherlands’ that was held on 4 November 2021. About one hundred researchers and policymakers exchanged knowledge about the latest research results from fifteen breakthrough projects within the ZonMw research programme ‘Microplastics and Health’.
Vidi funding has been awarded to 109 researchers from the scientific fields of domain Science (ENW | 42), Applied and Technical Sciences (AES | 13), Social Sciences and Humanities (SSH | 35), and Healthcare Research and Medical Sciences (ZonMw | 19). With the help of the Vidi grant, researchers can further develop their own line of research.
For the ZonMw Open Competition funding 2023, a total of 29 research teams received funding from a total budget of € 23 million. With this funding, all of the research groups can initiate innovative team science initiatives that contribute to long-term innovation within fundamental (bio)medical science and healthcare.
Clinical fellows awarded to 17 medical specialist who will serve as a bridge between clinical practice and scientific research.
NWO has awarded Veni funding of up to EUR 280,000 to 188 promising researchers from the full breadth of science. This will allow the laureates to further develop their own research ideas over the next three years.
In the ZonMw Open Competition 2024 round, a total of 29 research teams have been selected to receive funding from a total budget of €24 million. This funding enables the research groups to develop innovative team science initiatives that contribute to the long-term advancement of fundamental (bio)medical science and healthcare.- Bacteria are increasingly becoming resistant to antibiotics. This is an immediate threat to health care in the Netherlands and elsewhere. Recent studies show that, in Europe alone, more than 30.000 individuals die every year due to an infection with an antibiotic-resistant bacterium.
- Infections caused by bacteria resistant to most antibiotics (so-called multidrug resistant bacteria) remain a global problem. The lack of new antibiotics is a major social problem and threat to human and animal health.
- The rapid spread of multidrug resistant bacteria threatens the treatment of even simple infections in the near future. However, little is known about how bacteria develop resistance on surfaces. The aim of this project was to investigate fundamental mechanisms that shape antimicrobial resistance in biofilms in relation to the surface and then translate those findings into clinical practice.
- Respiratory tract infections are common and are increasingly caused by bacteria that are no longer sensitive to commonly used antibiotics. This project aimed to expand the therapeutic arsenal against respiratory tract infections by testing agents that stimulate the immune system. The AMC had 2 specific tasks.
- Read more about the research project on immune responses to against microbiota as biomarkers for ME/CFS.